BiotechTube

Nivolumab + Ipilimumab + Gemcitabine + Cisplatin + Carboplatin

Phase 3Active
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Urothelial Cancer

Conditions

Urothelial Cancer

Trial Timeline

Mar 24, 2017 → May 15, 2026

NCT ID
NCT03036098

About Nivolumab + Ipilimumab + Gemcitabine + Cisplatin + Carboplatin

Nivolumab + Ipilimumab + Gemcitabine + Cisplatin + Carboplatin is a phase 3 stage product being developed by Ono Pharmaceutical for Urothelial Cancer. The current trial status is active. This product is registered under clinical trial identifier NCT03036098. Target conditions include Urothelial Cancer.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03036098Phase 3Active

Competing Products

20 competing products in Urothelial Cancer

See all competitors
ProductCompanyStageHype Score
Dato-DXd + Carboplatin + Cisplatin + GemcitabineDaiichi SankyoPhase 2/3
65
Trastuzumab deruxtecanDaiichi SankyoPhase 2
52
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
52
Enfortumab vedotin + Pembrolizumab + Cisplatin + Carboplatin + GemcitabineAstellas PharmaPhase 3
77
PF-08634404 + Enfortumab VedotinAstellas PharmaPhase 1/2
41
Enfortumab vedotinAstellas PharmaPhase 1
33
AGS15EAstellas PharmaPhase 1
33
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
52
enfortumab vedotin (EV)Astellas PharmaPre-clinical
23
Enfortumab VedotinAstellas PharmaPhase 2
52
Enfortumab VedotinAstellas PharmaApproved
85
Enfortumab vedotinAstellas PharmaPhase 2
52
Enfortumab VedotinAstellas PharmaPre-clinical
23
enfortumab vedotinAstellas PharmaPhase 1
33
Eribulin Mesylate + AvelumabEisaiPhase 1
33
Pembrolizumab + Lenvatinib + Placebo for lenvatinibEisaiPhase 3
77
KHK2455 + AvelumabKyowa KirinPhase 1
33
Nivolumab 100 MG in 10 ML InjectionOno PharmaceuticalPhase 2
52
Ramucirumab + Docetaxel + PlaceboEli LillyPhase 3
77
Livmoniplimab + Budigalimab + Docetaxel + Paclitaxel + Docetaxel + Paclitaxel + GemcitabineAbbViePhase 2
52

Other Products from Ono Pharmaceutical

Sivelestat sodium hydrate + Sivelestat sodium hydrateApproved
85
Abatacept + Placebo matching with Abatacept + MethotrexateApproved
85
Rivastigmine transdermal patchApproved
85
Sitagliptin phosphatePhase 3
77
ONO-4538 + Carboplatin + Paclitaxel + Bevacizumab + PlaceboPhase 3
77